Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that is clinically heterogeneous and affects multiple organs particularly the kidney. Lupus nephritis is a common and severe manifestation of SLE in which immune-mediated inflammation can lead to permanent damage within the kidney, resulting in end stage renal failure. Recently a renal biopsy showed lupus nephritis on a 40-year old female without any other features of SLE such as clinical symptoms and autoantibodies including antinuclear antibody and anti-dsDNA. The renal biopsy showed that histopathological change of global and segmental sclerosis of glomeluri, diffuse proliferative nephritis with crescent formation compatible with class IV lupus nephritis. She was treated with systemic corticosteroids and pulse cyclophosphamide, followed by mycofenolate mofetil. During two years of follow-up, there have been no clinical or laboratory findings to meet the diagnostic criteria of SLE, suggesting that isolated lupus nephritis could occur without SLE.
INTRODUCTION
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that is characterized by the production of autoantibodies to nuclear and cytoplasmic antigens and could affect multiple organ systems including kidney [1] . In particular, renal involvement such as lupus nephritis (LN) is a common manifestation in SLE in which autoantibodies are thought to participate in the formation of glomerular immune complexes, initiating the inflammatory responses [2, 3] . Renal involvement in SLE is still one of the strongest predictors for morbidity and mortality. Depending on the studied population, LN occurs in 43% to 55% of SLE patients and usually within the first year of disease. In some aggressive cases such as class IV LN, up to 25% of LN patients develop end-stage renal disease (ESRD) 10 years after onset of renal disease [4, 5] .
Antinuclear antibody (ANA) elevated in the serum form the mainstay of serologic testing for the diagnosis of SLE, having a frequency of 95% in patients with SLE [6, 7] . Nevertheless, cases of SLE with a negative ANA have been reported, meaning that a negative ANA in serology could not rule out SLE [8, 9] . We report a case with isolated LN characterized by pathological findings without other clinical and serologic abnormalities compatible with the diagnosis of SLE.
CASE REPORT
A 40-year-old female with no family history of renal or autoimmune disease was noted to have proteinuria during a routine examination which was performed as part of prenatal screening program four years ago. At this point, the patient decided to not receive treatment at that time. Recently, she was found to have proteinuria again during an annual health check. Her blood pressure was 120/80 mm Hg, the pulse rate 78/min, the respiratory rate 20/ min and the body temperature 36.5°C. She had white blood cell count of 8,180/mm 3 (range, 3,700 to 9,000/mm , and C1q deposits in glomerular capillary walls and in the mesangium (Fig. 2) . Electron microscopy showed global mesangial and subendothelial electron-dense deposits (Fig. 3) .
The patient was given three monthly Intravenous cyclophosphamide (500 mg once a month) treatments in conjunction with 
DISCUSSION
The diagnosis of SLE is based on clinical and laboratory criteria developed by the American College of Rheumatology. A person has SLE if any 4 out of 11 criteria are present simultaneously or serially on two separate occasions [10] . However, a diagnosis of SLE can be made in a patient having fewer than four of these symptoms.
In fact, small groups of patients with SLE have been reported to have negative ANA and negative anti-DNA antibody. Even if a single kidney biopsy finding does not fulfill the accepted diagnostic criteria of SLE, the specific pathological features in LN could be considered to make a diagnosis of this as 'isolated LN' [9] . The exact underlying mechanisms in the pathogenesis of LN are still not well understood. LN has been considered as a classical immune complex-induced glomerulonephritis due to deposition of preformed circulating immune complexes that stain dominantly for IgG or binding of autoantibodies to glomerular antigens [2] . A diffuse proliferative LN (class IV) is both the most common and the most severe subtype. In this LN, more than 50% of glomeruli are involved which can be segmental or global, and active or chronic, with endocapillary or extracapillary proliferative lesions. Using
